Charcot Leyden crystals in acute myeloid leukemia

American Journal of Hematology

Volumn 73, Issue 2, 2003, Pages 141-

  Ahluwalia, Jasmina ^a   Das, Reena ^a   Malhotra, Pankaj ^a   Verma, Subhash ^a   Garewal, Gurjeewan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHARCOT LEYDEN PROTEIN; GALECTIN; GALECTIN 1; GALECTIN 2; LYSOPHOSPHOLIPASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANOREXIA; BONE MARROW BIOPSY; CASE REPORT; CHARCOT LEYDEN CRYSTAL; CRYSTAL; EDEMA; FEMALE; FEVER; GRANULOCYTE; HEPATOMEGALY; HUMAN; LETTER; LEUKOCYTOSIS; PALLOR; PRIORITY JOURNAL; THROMBOCYTOPENIA; WEIGHT REDUCTION;

BODY FLUIDS; CRYSTALLIZATION; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED;

EID: 0037947667     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10316     Document Type: Letter

References (5)

1. Weller PF, Bach DS, Austen KF. Biochemical characterization of Charcot Leyden crystal protein (lysophospholipase). J Biol Chem 1984;259:151.
2. Arora VK, Singh N, Bhatia A. Charcot Leyden crystals in fine needle aspiration cytology. Acta Cytol 1997;41(2):409-412.
3. Ma SK, Wong KF, Chan JK, Kwog YL. Refractory cytopenia with t(1,7) + 8 abnormality and dysplastic eosinophils showing intranuclear Charcot Leyden crystals: a fluorescence in situ hybridization study. Br J Haematol 1995;90(1):216-218.
4. Strauchen JA, Gordon RE. Crystalline inclusions in granulocytic sarcoma. Arch Pathol Lab Med 2002(Jan);126(1):85-86.
5. Carson HJ, Pelletiere EV. Clinically occult mixed cellularity Hodgkin's disease with Charcot Leyden crystals. Leuk Lymphoma 1996;23(1-2):153-157.